BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18272374)

  • 21. Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease.
    Raygani AV; Zahrai M; Soltanzadeh A; Doosti M; Javadi E; Pourmotabbed T
    Neurosci Lett; 2004 Nov; 371(2-3):142-6. PubMed ID: 15519745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
    Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
    Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic interaction between tau and the apolipoprotein E receptor LRP1 Increases Alzheimer's disease risk.
    Vázquez-Higuera JL; Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Pozueta A; Infante J; Berciano J; Combarros O
    Dement Geriatr Cogn Disord; 2009; 28(2):116-20. PubMed ID: 19684401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 14-3-3 zeta and tau genes interactively decrease Alzheimer's disease risk.
    Mateo I; Sánchez-Juan P; Rodríguez-Rodríguez E; Infante J; Fernández-Viadero C; Peña N; Berciano J; Combarros O
    Dement Geriatr Cogn Disord; 2008; 25(4):317-20. PubMed ID: 18319590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association analysis of methionine synthase gene 2756 A>G polymorphism and Alzheimer disease in a Chinese population.
    Zhao HL; Li XQ; Zhang ZX; Bi XH; Wang B; Zhang JW
    Brain Res; 2008 Apr; 1204():118-22. PubMed ID: 18329006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association study of the vascular endothelial growth factor gene with the risk of developing Alzheimer's disease.
    Chapuis J; Tian J; Shi J; Bensemain F; Cottel D; Lendon C; Amouyel P; Mann D; Lambert JC
    Neurobiol Aging; 2006 Sep; 27(9):1212-5. PubMed ID: 16154235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GAB2 polymorphism rs2373115 confers susceptibility to sporadic Alzheimer's disease.
    Jin C; Wu CZ; Liu X; Zhang F; Tian L; Yuan J; Wang G; Cheng Z
    Neurosci Lett; 2013 Nov; 556():216-20. PubMed ID: 24161894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: a case-control study.
    Quan W; Yasuda M; Hashimoto M; Yamamoto Y; Ishii K; Kazui H; Mori E; Kakigi T; Maeda K
    J Neurol Sci; 2006 Jan; 240(1-2):71-5. PubMed ID: 16233903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Presenilin 1 polymorphism associated with Alzheimer's disease in apolipoprotein E4 carriers.
    Martínez-García A; Aldudo J; Recuero M; Sastre I; Vilella-Cuadrada E; Rosich-Estragó M; Frank A; Valdivieso F; Bullido MJ
    Dement Geriatr Cogn Disord; 2008; 26(5):440-4. PubMed ID: 18957849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cystatin C and apoe polymorphisms in Italian Alzheimer's disease.
    Nacmias B; Bagnoli S; Tedde A; Cellini E; Guarnieri BM; Bartoli A; Serio A; Piacentini S; Sorbi S
    Neurosci Lett; 2006 Jan; 392(1-2):110-3. PubMed ID: 16188386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new promoter polymorphism in the alpha-1-antichymotrypsin gene is a disease modifier of Alzheimer's disease.
    Licastro F; Chiappelli M; Grimaldi LM; Morgan K; Kalsheker N; Calabrese E; Ritchie A; Porcellini E; Salani G; Franceschi M; Canal N
    Neurobiol Aging; 2005 Apr; 26(4):449-53. PubMed ID: 15653173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Ser326Cys polymorphism in the DNA repair gene hOGG1 is not associated with sporadic Alzheimer's disease.
    Coppedè F; Mancuso M; Lo Gerfo A; Manca ML; Petrozzi L; Migliore L; Siciliano G; Murri L
    Neurosci Lett; 2007 Mar; 414(3):282-5. PubMed ID: 17240059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic variations in tau-tubulin kinase-1 are linked to Alzheimer's disease in a Spanish case-control cohort.
    Vázquez-Higuera JL; Martínez-García A; Sánchez-Juan P; Rodríguez-Rodríguez E; Mateo I; Pozueta A; Frank A; Valdivieso F; Berciano J; Bullido MJ; Combarros O
    Neurobiol Aging; 2011 Mar; 32(3):550.e5-9. PubMed ID: 20096481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease.
    Ma SL; Tang NL; Lam LC; Chiu HF
    Neurobiol Aging; 2005 Jul; 26(7):1005-10. PubMed ID: 15748779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism and risk of Alzheimer's disease in Italians.
    Pola R; Flex A; Gaetani E; Proia AS; Papaleo P; Di Giorgio A; Straface G; Pecorini G; Serricchio M; Pola P
    Exp Gerontol; 2004 Aug; 39(8):1249-52. PubMed ID: 15288699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk-reducing effect of education in Alzheimer's disease.
    Sando SB; Melquist S; Cannon A; Hutton M; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly J
    Int J Geriatr Psychiatry; 2008 Nov; 23(11):1156-62. PubMed ID: 18484674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis of clusterin gene (CLU/APOJ) polymorphism in Alzheimer's disease patients and in normal cohorts from Russian populations].
    Golenkina SA; Gol'tsov AIu; Kuznetsova IL; Grigorenko AP; Andreeva TV; Reshetov DA; Kunizheva SS; Shagam LI; Morozova IIu; Goldenkova-Pavlova IV; Shimshilashvili Kh; Viacheslavova AO; Faskhutdinova G; Gareeva AÉ; Zaĭnullina AG; Khusnutdinova ÉK; Puzyrev VP; Stepanov VA; Kolotvin AV; Samokhodskaia LM; Selezneva ND; Gavrilova SI; Rogaev EI
    Mol Biol (Mosk); 2010; 44(4):620-6. PubMed ID: 20873220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tenomodulin variants, APOE and Alzheimer's disease in a Finnish case-control cohort.
    Tolppanen AM; Helisalmi S; Hiltunen M; Kolehmainen M; Schwab U; Pirttilä T; Pulkkinen L; Uusitupa M; Soininen H
    Neurobiol Aging; 2011 Mar; 32(3):546.e7-9. PubMed ID: 19524323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tau haplotypes and ApoE4 do not act in synergy on Alzheimer's disease.
    Almos PZ; Horváth S; Czibula A; Raskó I; Domján N; Juhász A; Janka Z; Kálmán J
    Psychiatry Res; 2011 Apr; 186(2-3):448-50. PubMed ID: 20837363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene dose-dependent association of interleukin-1A [-889] allele 2 polymorphism with Alzheimer's disease.
    Combarros O; Sánchez-Guerra M; Infante J; Llorca J; Berciano J
    J Neurol; 2002 Sep; 249(9):1242-5. PubMed ID: 12242547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.